AU506080B2 - Use of flunisolide to treat respiratory diseases - Google Patents

Use of flunisolide to treat respiratory diseases

Info

Publication number
AU506080B2
AU506080B2 AU14301/76A AU1430176A AU506080B2 AU 506080 B2 AU506080 B2 AU 506080B2 AU 14301/76 A AU14301/76 A AU 14301/76A AU 1430176 A AU1430176 A AU 1430176A AU 506080 B2 AU506080 B2 AU 506080B2
Authority
AU
Australia
Prior art keywords
flunisolide
respiratory diseases
treat respiratory
treat
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU14301/76A
Other languages
English (en)
Other versions
AU1430176A (en
Inventor
John H. Fried
Gisela T. Haringa
Richard E. Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of AU1430176A publication Critical patent/AU1430176A/en
Application granted granted Critical
Publication of AU506080B2 publication Critical patent/AU506080B2/en
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
AU14301/76A 1975-05-27 1976-05-26 Use of flunisolide to treat respiratory diseases Expired AU506080B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58130175A 1975-05-27 1975-05-27
US58130075A 1975-05-27 1975-05-27
US581300 1975-05-27
US581301 1975-05-27

Publications (2)

Publication Number Publication Date
AU1430176A AU1430176A (en) 1977-12-01
AU506080B2 true AU506080B2 (en) 1979-12-13

Family

ID=27078279

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14301/76A Expired AU506080B2 (en) 1975-05-27 1976-05-26 Use of flunisolide to treat respiratory diseases

Country Status (15)

Country Link
JP (1) JPS51144719A (sv)
AT (1) AT357702B (sv)
AU (1) AU506080B2 (sv)
CA (1) CA1075228A (sv)
DE (2) DE2661037C2 (sv)
ES (1) ES448220A1 (sv)
FR (1) FR2361900A1 (sv)
GB (1) GB1525181A (sv)
HK (1) HK8580A (sv)
IL (1) IL49652A (sv)
MX (1) MX3864E (sv)
MY (1) MY8000275A (sv)
NL (1) NL191234C (sv)
NZ (1) NZ180946A (sv)
SE (1) SE421426B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55154997A (en) * 1979-05-21 1980-12-02 Syntex Corp Manufacture of flunisolide having peculiar crystal form
EP0039369B1 (en) * 1980-05-02 1983-06-15 Schering Corporation Beclomethasone ester solvates, process for their preparation, and preparation of a formulation
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
KR0132576B1 (ko) * 1988-10-05 1998-04-17 로렌스 티. 웰츠 항-용매 내로의 침전을 통한 미분 고형물 결정 분말의 제조 방법
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
IL122752A (en) * 1995-06-27 2001-07-24 Boehringer Ingelheim Kg Stable preparations for creating propellant-free sprays
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
EP1273292B1 (en) 2001-07-02 2004-05-26 CHIESI FARMACEUTICI S.p.A. Optimised formulation of tobramycin for aerosolization
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN105188758A (zh) * 2013-03-15 2015-12-23 梅迪奇斯医药公司 氟尼缩松的局部组合物及治疗方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
BE585432A (fr) * 1958-12-08 1960-06-08 American Cyanamid Co Stéroïdes fluorés.
US3282791A (en) 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
FR2038105A1 (fr) 1969-04-01 1971-01-08 Syntex Corp Composition anti-inflammatoire locale et son mode d'utilisation
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
DE2332663C2 (de) 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
CA1075228A (en) 1980-04-08
MY8000275A (en) 1980-12-31
NZ180946A (en) 1978-07-28
HK8580A (en) 1980-03-14
FR2361900B1 (sv) 1979-04-13
SE421426B (sv) 1981-12-21
GB1525181A (en) 1978-09-20
SE7605927L (sv) 1976-11-28
DE2624924C2 (de) 1986-11-27
NL7605699A (nl) 1976-11-30
ES448220A1 (es) 1977-11-01
IL49652A (en) 1979-05-31
AU1430176A (en) 1977-12-01
DE2624924A1 (de) 1977-12-15
NL191234C (nl) 1995-04-03
ATA388376A (de) 1979-12-15
FR2361900A1 (fr) 1978-03-17
JPS6247880B2 (sv) 1987-10-09
DE2661037C2 (sv) 1989-04-06
MX3864E (es) 1981-08-26
IL49652A0 (en) 1976-07-30
AT357702B (de) 1980-07-25
JPS51144719A (en) 1976-12-13
NL191234B (nl) 1994-11-01

Similar Documents

Publication Publication Date Title
AU506080B2 (en) Use of flunisolide to treat respiratory diseases
GB1550835A (en) Treatment of tobacco
AU504474B2 (en) Inhalation of medicaments
CA1015653A (en) Treatment of natural gas
NZ180042A (en) Mixture of corticosteroids:dermatoses treatment
GB1540441A (en) Treatment of blood plasma
ZA763339B (en) Treatment of pigment
AU505867B2 (en) Treatment of ruminants
GB1554283A (en) Treatment of glass
ZA762669B (en) Treatment of neoplasias
GB2022998B (en) Phermaceutical composition for the treatment of neoplasticand other diseases
PT64945A (en) Preparation of therapeutic compounds
ZA708400B (en) Improvements relating to the treatment of obstructive diseases of the respiratory tract
JPS5218810A (en) Complex medical composition of estrogennprostaglangin
ZA763131B (en) Use of flunisolide to treat respiratory diseases
CA988418A (en) Agents for inhalation therapy of bronchial diseases
AU514663B2 (en) Treatment of asthma
MY8800128A (en) Preparation of post-masectomy treatment medicant
PH13398A (en) Use of flunisolide to treat respiratory diseases
JPS5242997A (en) Treatment of wool
PH12349A (en) Treatment of seedlings
ZA765293B (en) Treatment of electrodes
AU506773B2 (en) Compositions for treatment of cardiac rhythm disturbance
AU494524B2 (en) Treatment of tire making components
PH11108A (en) Treatment of smoking mixtures